Search

Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.

… Saturday, June 2, 2007 Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy

Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers.

… Thursday, March 1, 2012 Summary Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers. Ping Chi has been named an incumbent of a Geoffrey Beene

The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education.

… Monday, June 10, 2024 The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education. Infographic text: The Society raised an extraordinary

In this Q&A, medical oncologist Martee Hensley discusses the diagnosis and treatment of leiomyosarcoma and other uterine sarcomas.

… Thursday, July 14, 2016 Summary Memorial Sloan Kettering has a team of experts who specialize in the diagnosis and treatment of uterine sarcomas . Here, medical oncologist Martee Hensley tells us the latest developments in leiomyosarcoma and how our team approach benefits people with these rare cancers

Women who have reconstructive surgery after mastectomy and radiation for breast cancer are usually more satisfied with the results when their own tissue is used instead of implants.

… Thursday, December 8, 2016 Summary Women undergoing mastectomy for breast cancer have two main options for reconstructive surgery : artificial implants or flap surgery using their own tissue. A new study looked at these options in women who received radiation after mastectomy and found that those whose

A new drug for ovarian cancer, which was developed based on lab research at MSK, is transforming the possibilities for patients like Ellen Coopersmith.

… Thursday, September 11, 2025 VIDEO | 02:38 Watch How a Lab Discovery Sparked New Treatment for Rare Ovarian Cancer Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients meet the

The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the American Association for Thoracic Surgery and the Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK).

… Friday, March 15, 2024 The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the  American Association for Thoracic Surgery and the  Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK). TSOG is a network of thoracic surgeons

The Peritoneal Surface Malignancies Consortium Group is a national, multidisciplinary collaboration of surgical and medical gastrointestinal oncology specialists from top cancer centers. The group recently published a series of updated consensus guidelines for the clinical management of peritoneal metastases related to a variety of gastrointestinal malignancies. In this Q&A with Dr. Michael Foote we discuss discuss the major updates for the management of colorectal cancer and appendiceal cancer peritoneal metastases and how the changes will improve patient outcomes and streamline patient care.

… Tuesday, December 23, 2025 A Q&A with  Michael Foote, MD , MSK Gastrointestinal Medical Oncologist and member of the Peritoneal Surface Malignancies Consortium Group The Peritoneal Surface Malignancies Consortium Group (PSM Consortium Group) is a national, multidisciplinary collaboration of surgical

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, August 31, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Vinod Balachandran Awarded the 2023 FNIH Trailblazer Prize for Clinician-Scientists Vinod Balachandran, MD , hepatopancreatobiliary surgeon, was awarded the  2023 Trailblazer

The broad-spectrum antibiotic piperacillin-tazobactam used as perioperative prophylaxis significantly reduced surgical site infection (SSI) in patients undergoing open pancreatoduodenectomy (PD, or the Whipple procedure) compared with the standard-of-care cefoxitin, according to results from the first-ever registry-linked surgical clinical trial conducted in North America. The findings, published in JAMA on April 20, support using piperacillin-tazobactam as a standard of care for this patient population.

… Thursday, April 20, 2023 The broad-spectrum antibiotic piperacillin-tazobactam used as perioperative prophylaxis significantly reduced surgical site infection (SSI) in patients undergoing open pancreatoduodenectomy (PD, or the Whipple procedure) compared with the standard-of-care cefoxitin, according